{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:36:12Z","timestamp":1791909372169,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.hpb.2023.06.015","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T18:34:52Z","timestamp":1687631692000},"page":"1268-1277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemoradiotherapy \u2013 comparison of T category between the American Joint Committee on Cancer and Japan Pancreas Society"],"prefix":"10.1016","volume":"25","author":[{"given":"Aoi","family":"Hayasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-544X","authenticated-orcid":false,"given":"Shugo","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonori","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Kaluba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7846-3748","authenticated-orcid":false,"given":"Koki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9474-1541","authenticated-orcid":false,"given":"Toru","family":"Shinkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Gyoten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5522-7136","authenticated-orcid":false,"given":"Yusuke","family":"Iizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6802-8611","authenticated-orcid":false,"given":"Akihiro","family":"Tanemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5997-4342","authenticated-orcid":false,"given":"Yasuhiro","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9668-0500","authenticated-orcid":false,"given":"Naohisa","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-4498","authenticated-orcid":false,"given":"Shuji","family":"Isaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4408-2960","authenticated-orcid":false,"given":"Masashi","family":"Kishiwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2023.06.015_bib1","series-title":"AJCC Cancer Staging Manual. Eighth","year":"2016"},{"key":"10.1016\/j.hpb.2023.06.015_bib2","series-title":"The AJCC Cancer Staging Manual","author":"Edge","year":"2010"},{"key":"10.1016\/j.hpb.2023.06.015_bib3","series-title":"Classification of Pancreatic Carcinoma","year":"2016"},{"key":"10.1016\/j.hpb.2023.06.015_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/SLA.0000000000001763","article-title":"Multi-institutional validation study of the American Joint Commission on Cancer (8th Edition) changes for T and N staging in patients with pancreatic adenocarcinoma","volume":"265","author":"Allen","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.06.015_bib5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jhbp.577","article-title":"Multinational validation of the American Joint Committee on Cancer 8th edition pancreatic cancer staging system in a pancreas head cancer cohort","volume":"25","author":"Kwon","year":"2018","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.hpb.2023.06.015_bib6","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/MPA.0000000000001349","article-title":"Impact of changes in the American Joint Committee on Cancer staging manual, eighth edition, for pancreatic ductal adenocarcinoma","volume":"48","author":"Kassardjian","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2023.06.015_bib7","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1245\/s10434-017-5864-9","article-title":"Duodenal involvement is an independent prognostic factor for patients with surgically resected pancreatic ductal adenocarcinoma","volume":"24","author":"Dal Molin","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.06.015_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MPA.0000000000001547","article-title":"Extrapancreatic nerve plexus invasion on imaging predicts poor survival after upfront surgery for anatomically resectable pancreatic cancer","volume":"49","author":"Sugimoto","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2023.06.015_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/SLA.0b013e318237872e","article-title":"Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer","volume":"255","author":"Nakao","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.06.015_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pan.2017.11.011","article-title":"International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017","volume":"18","author":"Isaji","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.hpb.2023.06.015_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/cancers10030065","article-title":"Survival analysis in patients with pancreatic ductal adenocarcinoma undergoing chemoradiotherapy followed by surgery according to the international consensus on the 2017 definition of borderline resectable cancer","volume":"10","author":"Hayasaki","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hpb.2023.06.015_bib12","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1097\/SLA.0000000000004148","volume":"275","author":"Kato","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.06.015_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MPA.0000000000001227","article-title":"Comparative study between gemcitabine-based and gemcitabine plus S1-based preoperative chemoradiotherapy for localized pancreatic ductal adenocarcinoma, with special attention to initially locally advanced unresectable tumor","volume":"48","author":"Takeuchi","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2023.06.015_bib14","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2023.06.015_bib15","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2023.06.015_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00534-013-0616-0","volume":"20","author":"Satoi","year":"2013","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.hpb.2023.06.015_bib17","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(01)06651-X","article-title":"Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial","volume":"358","author":"Neoptolemos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.hpb.2023.06.015_bib18","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2023.06.015_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000267","article-title":"Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages","volume":"7","author":"Gillen","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.hpb.2023.06.015_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.06.015_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2023.06.015_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00330-021-08180-6","article-title":"CT-diagnosed extra-pancreatic extension of pancreatic ductal adenocarcinoma is a more reliable prognostic factor for survival than pathology-diagnosed extension","volume":"32","author":"Toshima","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.hpb.2023.06.015_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00423-010-0593-6","article-title":"Comparison of the long-term outcomes of uncinate process cancer and non-uncinate process pancreas head cancer: poor prognosis accompanied by early locoregional recurrence","volume":"395","author":"Kang","year":"2010","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.hpb.2023.06.015_bib24","first-page":"1242","article-title":"Comparison of uncinate process cancer and non-uncinate process pancreatic head cancer","volume":"7","author":"Liu","year":"2016","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.hpb.2023.06.015_bib25","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.2147\/OTT.S145708","article-title":"Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis","volume":"10","author":"Meng","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.hpb.2023.06.015_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/SLA.0000000000003284","article-title":"Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline\/locally advanced pancreatic cancer","volume":"273","author":"Truty","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.06.015_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MPA.0000000000000059","article-title":"Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expression","volume":"43","author":"Kobayashi","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2023.06.015_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijsu.2018.01.043","article-title":"Correlation of clinical and pathological staging and response to neoadjuvant therapy in resected pancreatic cancer","volume":"52","author":"Mirkin","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.hpb.2023.06.015_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/SLA.0000000000001850","article-title":"Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients","volume":"264","author":"Hackert","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.06.015_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/SLA.0000000000004915","article-title":"Surgical Decision-Making in Pancreatic Ductal Adenocarcinoma: Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant Chemotherapy","volume":"277","author":"Habib","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.06.015_bib31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/SLA.0000000000004155","article-title":"Surgical outcome results from SWOG S1505: a randomized clinical trial of mFOLFIRINOX versus gemcitabine\/nab-paclitaxel for perioperative treatment of resectable pancreatic ductal adenocarcinoma","volume":"272","author":"Ahmad","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.06.015_bib32","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2023.06.015_bib33","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1245\/s10434-018-07131-8","article-title":"Clinical impact of neoadjuvant chemotherapy and chemoradiotherapy in borderline resectable pancreatic cancer: analysis of 884 patients at facilities specializing in pancreatic surgery","volume":"26","author":"Nagakawa","year":"2019","journal-title":"Ann Surg Oncol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X23005701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X23005701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:41:08Z","timestamp":1761266468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X23005701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1365182X23005701"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2023.06.015","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemoradiotherapy \u2013 comparison of T category between the American Joint Committee on Cancer and Japan Pancreas Society","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2023.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc.","name":"copyright","label":"Copyright"}]}}